Cargando…

Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex

Although the human peptide-loading complex (PLC) is required for optimal major histocompatibility complex class I (MHC I) antigen presentation, its composition is still incompletely understood. The ratio of the transporter associated with antigen processing (TAP) and MHC I to tapasin, which is respo...

Descripción completa

Detalles Bibliográficos
Autores principales: Panter, Michaela S., Jain, Ankur, Leonhardt, Ralf M., Ha, Taekjip, Cresswell, Peter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Biochemistry and Molecular Biology 2012
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438949/
https://www.ncbi.nlm.nih.gov/pubmed/22829594
http://dx.doi.org/10.1074/jbc.M112.387704
_version_ 1782242942816092160
author Panter, Michaela S.
Jain, Ankur
Leonhardt, Ralf M.
Ha, Taekjip
Cresswell, Peter
author_facet Panter, Michaela S.
Jain, Ankur
Leonhardt, Ralf M.
Ha, Taekjip
Cresswell, Peter
author_sort Panter, Michaela S.
collection PubMed
description Although the human peptide-loading complex (PLC) is required for optimal major histocompatibility complex class I (MHC I) antigen presentation, its composition is still incompletely understood. The ratio of the transporter associated with antigen processing (TAP) and MHC I to tapasin, which is responsible for MHC I recruitment and peptide binding optimization, is particularly critical for modeling of the PLC. Here, we characterized the stoichiometry of the human PLC using both biophysical and biochemical approaches. By means of single-molecule pulldown (SiMPull), we determined a TAP/tapasin ratio of 1:2, consistent with previous studies of insect-cell microsomes, rat-human chimeric cells, and HeLa cells expressing truncated TAP subunits. We also report that the tapasin/MHC I ratio varies, with the PLC population comprising both 2:1 and 2:2 complexes, based on mutational and co-precipitation studies. The MHC I-saturated PLC may be particularly prevalent among peptide-selective alleles, such as HLA-C4. Additionally, MHC I association with the PLC increases when its peptide supply is reduced by inhibiting the proteasome or by blocking TAP-mediated peptide transport using viral inhibitors. Taken together, our results indicate that the composition of the human PLC varies under normal conditions and dynamically adapts to alterations in peptide supply that may arise during viral infection. These findings improve our understanding of the quality control of MHC I peptide loading and may aid the structural and functional modeling of the human PLC.
format Online
Article
Text
id pubmed-3438949
institution National Center for Biotechnology Information
language English
publishDate 2012
publisher American Society for Biochemistry and Molecular Biology
record_format MEDLINE/PubMed
spelling pubmed-34389492012-09-13 Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex Panter, Michaela S. Jain, Ankur Leonhardt, Ralf M. Ha, Taekjip Cresswell, Peter J Biol Chem Immunology Although the human peptide-loading complex (PLC) is required for optimal major histocompatibility complex class I (MHC I) antigen presentation, its composition is still incompletely understood. The ratio of the transporter associated with antigen processing (TAP) and MHC I to tapasin, which is responsible for MHC I recruitment and peptide binding optimization, is particularly critical for modeling of the PLC. Here, we characterized the stoichiometry of the human PLC using both biophysical and biochemical approaches. By means of single-molecule pulldown (SiMPull), we determined a TAP/tapasin ratio of 1:2, consistent with previous studies of insect-cell microsomes, rat-human chimeric cells, and HeLa cells expressing truncated TAP subunits. We also report that the tapasin/MHC I ratio varies, with the PLC population comprising both 2:1 and 2:2 complexes, based on mutational and co-precipitation studies. The MHC I-saturated PLC may be particularly prevalent among peptide-selective alleles, such as HLA-C4. Additionally, MHC I association with the PLC increases when its peptide supply is reduced by inhibiting the proteasome or by blocking TAP-mediated peptide transport using viral inhibitors. Taken together, our results indicate that the composition of the human PLC varies under normal conditions and dynamically adapts to alterations in peptide supply that may arise during viral infection. These findings improve our understanding of the quality control of MHC I peptide loading and may aid the structural and functional modeling of the human PLC. American Society for Biochemistry and Molecular Biology 2012-09-07 2012-07-24 /pmc/articles/PMC3438949/ /pubmed/22829594 http://dx.doi.org/10.1074/jbc.M112.387704 Text en © 2012 by The American Society for Biochemistry and Molecular Biology, Inc. Author's Choice—Final version full access. Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) applies to Author Choice Articles
spellingShingle Immunology
Panter, Michaela S.
Jain, Ankur
Leonhardt, Ralf M.
Ha, Taekjip
Cresswell, Peter
Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex
title Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex
title_full Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex
title_fullStr Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex
title_full_unstemmed Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex
title_short Dynamics of Major Histocompatibility Complex Class I Association with the Human Peptide-loading Complex
title_sort dynamics of major histocompatibility complex class i association with the human peptide-loading complex
topic Immunology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3438949/
https://www.ncbi.nlm.nih.gov/pubmed/22829594
http://dx.doi.org/10.1074/jbc.M112.387704
work_keys_str_mv AT pantermichaelas dynamicsofmajorhistocompatibilitycomplexclassiassociationwiththehumanpeptideloadingcomplex
AT jainankur dynamicsofmajorhistocompatibilitycomplexclassiassociationwiththehumanpeptideloadingcomplex
AT leonhardtralfm dynamicsofmajorhistocompatibilitycomplexclassiassociationwiththehumanpeptideloadingcomplex
AT hataekjip dynamicsofmajorhistocompatibilitycomplexclassiassociationwiththehumanpeptideloadingcomplex
AT cresswellpeter dynamicsofmajorhistocompatibilitycomplexclassiassociationwiththehumanpeptideloadingcomplex